The global stents market was valued at $11,749.4 million in 2020, and is estimated to reach $19,767.5 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030.
A stents is a medical device, which is inserted into internal duct of the body for expanding blood vessels and preventing vessels from blockage. Stents act by expanding vessels or internal duct for clearing the blockage caused due to deposition of plague. Natural stents are designed in such a way that after eluting a drug, the stents get dissolved within the body at a certain interval of time.
Growth of the global stents market is majorly driven by alarming increase in prevalence of cardiovascular disease; rise in government initiatives for development of effective treatment procedure; increase in number of angioplasty surgery; advancements in technology in the healthcare sector; and rise in geriatric population. For instance, according to the Centers for Disease Control and Prevention, in 2019, approximately 14.2% people above the age of 45 years were reported to be diagnosed with coronary artery disease across the globe. Moreover, in 2021, the Government of India announced a Scheme for “Promotion of Medical Device Parks”. It is an initiative taken by government to support the medical devices. Furthermore, in November 2019, the American College of Cardiology, announced that a physician conduct around 1.2 million angioplasties in the U.S., in a year. Thus, an increase in number of angioplasty surgery and rise in funds by governments and private organizations for development of medical devices is expected to propel growth of the market.
Increase in number of approval of stents and adoption of different strategy of market players in manufacturing of advanced stents are the major factors that drive the global stents market. Arterius Limited, in April 2019, collaborated with Translational Biomedical Research Centre for development of new bioabsorbable stents to get accurate and reliable results. Moreover, increase in incidences of chronic diseases such as diabetics and hypertension significantly contributes to the market growth. Rise in demand for stents acts a key driving force for expansion of the global market. Further, in March 2021, Elixir Medical Corporation, a developer of drug-eluting cardiovascular devices, announced the result of the INFINITY SWEDEHEART randomized controlled trial (RCT) of DynamX Coronary Bioadaptor system. The result states that dynamx Coronary bioadaptor has no target of myocardial infarction or thrombosis through 24 months.
For instance, in April 2021, the MicroPort Scientific Corporation launched Castor Branched Stents-Graft system, which is used for treatment of aortic arch repair by minimally invasive surgical procedure. Thus, advancements in technology for development of stents in emerging nations are anticipated to provide lucrative opportunities for the market expansion.
However, high cost of stents used for treatment of vascular blockage is anticipated to hinder the market growth. Rise in the healthcare sector for management of coronary and peripheral artery disease, rise in per capital income, and rise in adoption of stents by patients and physicians augments growth of the market. This has further encouraged many key players to enter emerging markets, thus offering lucrative growth opportunities for the stents market.
The global stents market is segmented into product, material, end user, and region. By product, the market is categorized into coronary stents, peripheral stents, and stents-related implant. Depending on material, it is fragmented into metallic biomaterials, polymer biomaterials and natural biomaterials. On the basis of end user, it is divided into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global stents market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.
Some of the major companies that operate in the global stents market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.
A stents is a medical device, which is inserted into internal duct of the body for expanding blood vessels and preventing vessels from blockage. Stents act by expanding vessels or internal duct for clearing the blockage caused due to deposition of plague. Natural stents are designed in such a way that after eluting a drug, the stents get dissolved within the body at a certain interval of time.
Growth of the global stents market is majorly driven by alarming increase in prevalence of cardiovascular disease; rise in government initiatives for development of effective treatment procedure; increase in number of angioplasty surgery; advancements in technology in the healthcare sector; and rise in geriatric population. For instance, according to the Centers for Disease Control and Prevention, in 2019, approximately 14.2% people above the age of 45 years were reported to be diagnosed with coronary artery disease across the globe. Moreover, in 2021, the Government of India announced a Scheme for “Promotion of Medical Device Parks”. It is an initiative taken by government to support the medical devices. Furthermore, in November 2019, the American College of Cardiology, announced that a physician conduct around 1.2 million angioplasties in the U.S., in a year. Thus, an increase in number of angioplasty surgery and rise in funds by governments and private organizations for development of medical devices is expected to propel growth of the market.
Increase in number of approval of stents and adoption of different strategy of market players in manufacturing of advanced stents are the major factors that drive the global stents market. Arterius Limited, in April 2019, collaborated with Translational Biomedical Research Centre for development of new bioabsorbable stents to get accurate and reliable results. Moreover, increase in incidences of chronic diseases such as diabetics and hypertension significantly contributes to the market growth. Rise in demand for stents acts a key driving force for expansion of the global market. Further, in March 2021, Elixir Medical Corporation, a developer of drug-eluting cardiovascular devices, announced the result of the INFINITY SWEDEHEART randomized controlled trial (RCT) of DynamX Coronary Bioadaptor system. The result states that dynamx Coronary bioadaptor has no target of myocardial infarction or thrombosis through 24 months.
For instance, in April 2021, the MicroPort Scientific Corporation launched Castor Branched Stents-Graft system, which is used for treatment of aortic arch repair by minimally invasive surgical procedure. Thus, advancements in technology for development of stents in emerging nations are anticipated to provide lucrative opportunities for the market expansion.
However, high cost of stents used for treatment of vascular blockage is anticipated to hinder the market growth. Rise in the healthcare sector for management of coronary and peripheral artery disease, rise in per capital income, and rise in adoption of stents by patients and physicians augments growth of the market. This has further encouraged many key players to enter emerging markets, thus offering lucrative growth opportunities for the stents market.
The global stents market is segmented into product, material, end user, and region. By product, the market is categorized into coronary stents, peripheral stents, and stents-related implant. Depending on material, it is fragmented into metallic biomaterials, polymer biomaterials and natural biomaterials. On the basis of end user, it is divided into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global stents market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.
Some of the major companies that operate in the global stents market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global stents market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global stents market.
KEY MARKET SEGMENTS
By Product
- Coronary Stents
- Drug-eluting stents (DES)
- Bare-metal coronary stents
- Bioabsorbable stents
- Peripheral Stents
- Iliac stent
- Femoral-popliteal stents
- Renal & related stents
- Carotid stents
- Stent Related Implant
- Synthetic grafts
- Vena cava filters
By Material
- Metallic Biomaterial
- Polymer Biomaterial
- Natural Biomaterial
By End User
- Hospital
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Abbott Laboratories
- B. Braun Melsungen AG
- Biotronik SE & CO. KG.
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Elixir Medical Corporation
- Medtronic Plc.
- Microport Scientific Corporation
- Reva Medical, Inc.
- Terumo Corporation
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: STENTS MARKET, BY PRODUCT
CHAPTER 5: STENTS MARKET, BY MATERIAL
CHAPTER 6: STENTS MARKET, BY END USER
CHAPTER 7: STENTS MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen Ag
- Biotronik Se & Co. Kg.
- Boston Scientific Corporation
- Becton
- Dickinson And Company
- Elixir Medical Corporation
- Medtronic Plc.
- Microport Scientific Corporation
- Reva Medical, Inc.
- Terumo Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 251 |
| Published | December 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 11749.4 million |
| Forecasted Market Value ( USD | $ 19767.5 million |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
